203 related articles for article (PubMed ID: 32356558)
1. Synj1 haploinsufficiency causes dopamine neuron vulnerability and alpha-synuclein accumulation in mice.
Pan PY; Sheehan P; Wang Q; Zhu X; Zhang Y; Choi I; Li X; Saenz J; Zhu J; Wang J; El Gaamouch F; Zhu L; Cai D; Yue Z
Hum Mol Genet; 2020 Aug; 29(14):2300-2312. PubMed ID: 32356558
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
[TBL] [Abstract][Full Text] [Related]
3. Synaptojanin1 Modifies Endolysosomal Parameters in Cultured Ventral Midbrain Neurons.
Zhu X; Prakash SS; McAuliffe G; Pan PY
eNeuro; 2023 May; 10(5):. PubMed ID: 37072173
[TBL] [Abstract][Full Text] [Related]
4. Synaptojanin1 deficiency upregulates basal autophagosome formation in astrocytes.
Pan PY; Zhu J; Rizvi A; Zhu X; Tanaka H; Dreyfus CF
J Biol Chem; 2021 Jul; 297(1):100873. PubMed ID: 34126070
[TBL] [Abstract][Full Text] [Related]
5. Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease.
Zou L; Zhang X; Xiong M; Meng L; Tian Y; Pan L; Yuan X; Chen G; Wang Z; Bu L; Yao Z; Zhang Z; Ye K; Zhang Z
Neurobiol Dis; 2021 Jul; 154():105326. PubMed ID: 33677035
[TBL] [Abstract][Full Text] [Related]
6. Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline.
Hardies K; Cai Y; Jardel C; Jansen AC; Cao M; May P; Djémié T; Hachon Le Camus C; Keymolen K; Deconinck T; Bhambhani V; Long C; Sajan SA; Helbig KL; ; Suls A; Balling R; Helbig I; De Jonghe P; Depienne C; De Camilli P; Weckhuysen S
Brain; 2016 Sep; 139(Pt 9):2420-30. PubMed ID: 27435091
[TBL] [Abstract][Full Text] [Related]
7. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
8. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
[TBL] [Abstract][Full Text] [Related]
9. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
[TBL] [Abstract][Full Text] [Related]
10. Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.
Rocha EM; Smith GA; Park E; Cao H; Brown E; Hayes MA; Beagan J; McLean JR; Izen SC; Perez-Torres E; Hallett PJ; Isacson O
Neurobiol Dis; 2015 Oct; 82():495-503. PubMed ID: 26392287
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease gene, Synaptojanin1, dysregulates the surface maintenance of the dopamine transporter.
Saenz J; Khezerlou E; Aggarwal M; Shaikh A; Ganti N; Herborg F; Pan PY
Res Sq; 2024 Mar; ():. PubMed ID: 38559229
[TBL] [Abstract][Full Text] [Related]
13. Mini-review: Synaptojanin 1 and its implications in membrane trafficking.
Choudhry H; Aggarwal M; Pan PY
Neurosci Lett; 2021 Nov; 765():136288. PubMed ID: 34637856
[TBL] [Abstract][Full Text] [Related]
14. α-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression.
Song DY; Yuan L; Cui N; Feng C; Meng L; Wang XH; Xiang M; Liu D; Wang C; Zhang Z; Li JY; Li W
J Neurochem; 2023 Nov; 167(3):461-484. PubMed ID: 37788328
[TBL] [Abstract][Full Text] [Related]
15. SYNJ1 rescues motor functions in hereditary and sporadic Parkinson's disease mice by upregulating TSP-1 expression.
Tian Y; Yi S; Guo W; Feng C; Zhang X; Dong H; Wang K; Li R; Tian Y; Gan M; Wu T; Xie H; Gao X
Behav Brain Res; 2023 Aug; 452():114569. PubMed ID: 37419331
[TBL] [Abstract][Full Text] [Related]
16. A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons.
Luo J; Sun L; Lin X; Liu G; Yu J; Parisiadou L; Xie C; Ding J; Cai H
Hum Mol Genet; 2014 Dec; 23(24):6567-74. PubMed ID: 25051958
[TBL] [Abstract][Full Text] [Related]
17. A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.
Chen L; Xie Z; Turkson S; Zhuang X
J Neurosci; 2015 Jan; 35(3):890-905. PubMed ID: 25609609
[TBL] [Abstract][Full Text] [Related]
18. Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.
Sucunza D; Rico AJ; Roda E; Collantes M; González-Aseguinolaza G; Rodríguez-Pérez AI; Peñuelas I; Vázquez A; Labandeira-García JL; Broccoli V; Lanciego JL
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062940
[TBL] [Abstract][Full Text] [Related]
19. Extracellular α-synuclein enters dopaminergic cells by modulating flotillin-1-assisted dopamine transporter endocytosis.
Kobayashi J; Hasegawa T; Sugeno N; Yoshida S; Akiyama T; Fujimori K; Hatakeyama H; Miki Y; Tomiyama A; Kawata Y; Fukuda M; Kawahata I; Yamakuni T; Ezura M; Kikuchi A; Baba T; Takeda A; Kanzaki M; Wakabayashi K; Okano H; Aoki M
FASEB J; 2019 Sep; 33(9):10240-10256. PubMed ID: 31211923
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS
Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
